ZA200301403B - Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain. - Google Patents

Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain. Download PDF

Info

Publication number: ZA200301403B
Authority: ZA; South Africa
Prior art keywords: formula; enantiomer; predominates; enantiomers; substantially free
Prior art date: 2000-07-21

Application number

ZA200301403A

Other languages

English (en)

Inventor

Ellen E Codd

Katherine E Rogers

Boyu Zhao

Richard P Shank

Carlos R Plata-Salaman

Original Assignee

Ortho Mcneil Pharm Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-21

Filing date

2003-02-20

Publication date

2004-06-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22820176&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200301403(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-02-20 Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc

2004-06-15 Publication of ZA200301403B publication Critical patent/ZA200301403B/en

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Organic Chemistry (AREA)
Emergency Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pain & Pain Management (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

ZA200301403A 2000-07-21 2003-02-20 Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain. ZA200301403B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US21965700P	2000-07-21	2000-07-21

Publications (1)

Publication Number	Publication Date
ZA200301403B true ZA200301403B (en)	2004-06-15

Family

ID=22820176

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200301403A ZA200301403B (en)	2000-07-21	2003-02-20	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain.

Country Status (28)

Country	Link
US (4)	US20020107283A1 (pl)
EP (1)	EP1305082B1 (pl)
JP (1)	JP5271473B2 (pl)
KR (1)	KR100792814B1 (pl)
CN (1)	CN1250213C (pl)
AT (1)	ATE267629T1 (pl)
AU (2)	AU7349301A (pl)
BG (1)	BG107529A (pl)
BR (1)	BR0112713A (pl)
CA (1)	CA2416819C (pl)
CZ (1)	CZ2003445A3 (pl)
DE (1)	DE60103546T2 (pl)
DK (1)	DK1305082T3 (pl)
EA (1)	EA005648B1 (pl)
ES (1)	ES2221651T3 (pl)
HU (1)	HUP0302940A3 (pl)
IL (2)	IL154052A0 (pl)
MX (1)	MXPA03000619A (pl)
MY (1)	MY127317A (pl)
NO (1)	NO330055B1 (pl)
NZ (1)	NZ523851A (pl)
PL (1)	PL365701A1 (pl)
PT (1)	PT1305082E (pl)
SK (1)	SK1962003A3 (pl)
TR (1)	TR200401511T4 (pl)
UA (1)	UA74195C2 (pl)
WO (1)	WO2002007822A2 (pl)
ZA (1)	ZA200301403B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2002067922A1 (en)	2001-02-27	2002-09-06	Ortho-Mcneil Pharmaceutical, Inc.	Carbamate compounds for use in the treatment of pain
PL368164A1 (pl)	2001-07-16	2005-03-21	Ortho-Mcneil Pharmaceutical, Inc.	Związki karbaminianowe do stosowania w zapobieganiu lub leczeniu bólu neuropatycznego i bólu związanego z bólem głowy i migreną
DK1406606T3 (da) *	2001-07-16	2007-03-05	Ortho Mcneil Pharm Inc	Carbamatforbindelser til forebyggelse eller behandling af neuropatisk smerte og smerte forbundet med klynge- og migrænehovedpine
US20040087642A1 (en) *	2002-10-24	2004-05-06	Zeldis Jerome B.	Methods of using and compositions comprising a JNK inhibitor for the treatment, prevention, management and/or modification of pain
WO2004054608A2 (en) *	2002-12-12	2004-07-01	Agennix Incorporated	Lactoferrin in the reduction of pain
WO2006047744A2 (en) *	2004-10-26	2006-05-04	Agennix Incorporated	Compositions of lactoferrin related peptides and uses thereof
EP1850841A1 (en) *	2005-01-20	2007-11-07	Janssen Pharmaceutica N.V.	Methods for qt interval control
EP2476433A1 (en)	2006-03-30	2012-07-18	GlaxoSmithKline Biologicals S.A.	Immunogenic composition
JP2010505952A (ja) *	2006-10-10	2010-02-25	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	（ｓ）−（＋）−２−（２−クロロフェニル）−２−ヒドロキシ−エチルカルバメートの新規結晶
US8609849B1 (en)	2010-11-30	2013-12-17	Fox Chase Chemical Diversity Center, Inc.	Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
US20150057351A1 (en) *	2013-08-22	2015-02-26	Sucampo Ag	Method for treating neuropathic pain

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3278380A (en) *	1962-02-06	1966-10-11	Armour Pharma	Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en)	1962-07-18	1966-08-09	Armour Pharma	Substituted phenethyl carbamates
HU191549B (en) *	1984-04-11	1987-03-30	Richter Gedeon Vegyeszet	Process for producing 1-/6-/2 comma above-substituted-5 comma above, 6 comma above, 7 comma above, 8 comma above-tetrahydro-4 comma above-oxo-quinazolino//-3,4-dihydro-6,7-disubstituted-isoquinoline derivatives
US4868190A (en) *	1988-12-27	1989-09-19	Hoechst-Roussel Pharmaceuticals, Inc.	N-pyridinyl-9H-carbazol-9-amines
GB9518027D0 (en) *	1995-09-05	1995-11-08	Wellcome Found	Pharmacologically active compound
US5698588A (en) *	1996-01-16	1997-12-16	Yukong Limited	Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
BR9810742A (pt) *	1997-06-05	2000-09-12	Sanofi Synthelabo	Derivados de 5-naftalen -1il-1,3-dioxana, preparação dos mesmos e aplicação em terapia
MXPA03007717A (es) *	2001-02-27	2005-11-08	Johnson & Johnson	Compuestos de carbamato para su uso en la prevencion o tratamiento de trastornos bipolares.
CN1262272C (zh) *	2001-02-27	2006-07-05	奥索-麦克尼尔药品公司	用于预防或治疗运动障碍的氨基甲酸酯化合物
US6541513B2 (en) *	2001-02-27	2003-04-01	Ortho-Mcneil Pharmaceutical, Inc.	Carbamate compounds for use in preventing or treating psychotic disorders

2001
- 2001-07-16 AU AU7349301A patent/AU7349301A/xx active Pending
- 2001-07-16 BR BR0112713-6A patent/BR0112713A/pt not_active Application Discontinuation
- 2001-07-16 IL IL15405201A patent/IL154052A0/xx unknown
- 2001-07-16 PT PT01952773T patent/PT1305082E/pt unknown
- 2001-07-16 MX MXPA03000619A patent/MXPA03000619A/es active IP Right Grant
- 2001-07-16 WO PCT/US2001/022322 patent/WO2002007822A2/en not_active Ceased
- 2001-07-16 KR KR1020037000914A patent/KR100792814B1/ko not_active Expired - Lifetime
- 2001-07-16 CZ CZ2003445A patent/CZ2003445A3/cs unknown
- 2001-07-16 CN CNB01815798XA patent/CN1250213C/zh not_active Expired - Fee Related
- 2001-07-16 EP EP01952773A patent/EP1305082B1/en not_active Expired - Lifetime
- 2001-07-16 TR TR2004/01511T patent/TR200401511T4/xx unknown
- 2001-07-16 EA EA200300042A patent/EA005648B1/ru not_active IP Right Cessation
- 2001-07-16 ES ES01952773T patent/ES2221651T3/es not_active Expired - Lifetime
- 2001-07-16 DE DE60103546T patent/DE60103546T2/de not_active Expired - Lifetime
- 2001-07-16 JP JP2002513552A patent/JP5271473B2/ja not_active Expired - Lifetime
- 2001-07-16 PL PL01365701A patent/PL365701A1/pl not_active Application Discontinuation
- 2001-07-16 AU AU2001273493A patent/AU2001273493B2/en not_active Ceased
- 2001-07-16 UA UA2003010559A patent/UA74195C2/uk unknown
- 2001-07-16 DK DK01952773T patent/DK1305082T3/da active
- 2001-07-16 CA CA2416819A patent/CA2416819C/en not_active Expired - Fee Related
- 2001-07-16 HU HU0302940A patent/HUP0302940A3/hu unknown
- 2001-07-16 US US09/906,251 patent/US20020107283A1/en not_active Abandoned
- 2001-07-16 AT AT01952773T patent/ATE267629T1/de not_active IP Right Cessation
- 2001-07-16 NZ NZ523851A patent/NZ523851A/en unknown
- 2001-07-16 SK SK196-2003A patent/SK1962003A3/sk unknown
- 2001-07-20 MY MYPI20013443 patent/MY127317A/en unknown
2003
- 2003-01-20 NO NO20030299A patent/NO330055B1/no not_active IP Right Cessation
- 2003-01-20 IL IL154052A patent/IL154052A/en unknown
- 2003-02-05 BG BG107529A patent/BG107529A/bg unknown
- 2003-02-20 ZA ZA200301403A patent/ZA200301403B/en unknown
2004
- 2004-06-15 US US10/868,633 patent/US20040266866A1/en not_active Abandoned
2005
- 2005-02-18 US US11/194,876 patent/US20060183795A1/en not_active Abandoned
2009
- 2009-07-20 US US12/505,765 patent/US20090281179A1/en not_active Abandoned

Also Published As

Publication number	Publication date
ES2221651T3 (es)	2005-01-01
DE60103546D1 (de)	2004-07-01
US20060183795A1 (en)	2006-08-17
CN1250213C (zh)	2006-04-12
NZ523851A (en)	2004-09-24
IL154052A (en)	2008-07-08
JP5271473B2 (ja)	2013-08-21
MXPA03000619A (es)	2004-07-30
WO2002007822A2 (en)	2002-01-31
PT1305082E (pt)	2004-09-30
EA200300042A1 (ru)	2003-06-26
BR0112713A (pt)	2003-07-22
TR200401511T4 (tr)	2004-08-23
US20040266866A1 (en)	2004-12-30
DK1305082T3 (da)	2004-09-13
AU7349301A (en)	2002-02-05
CZ2003445A3 (cs)	2004-08-18
CA2416819A1 (en)	2002-01-31
ATE267629T1 (de)	2004-06-15
MY127317A (en)	2006-11-30
EA005648B1 (ru)	2005-04-28
SK1962003A3 (en)	2004-08-03
KR100792814B1 (ko)	2008-01-14
KR20030022300A (ko)	2003-03-15
UA74195C2 (uk)	2005-11-15
IL154052A0 (en)	2003-07-31
EP1305082A2 (en)	2003-05-02
US20090281179A1 (en)	2009-11-12
HUP0302940A3 (en)	2012-02-28
CN1458853A (zh)	2003-11-26
JP2004504362A (ja)	2004-02-12
US20020107283A1 (en)	2002-08-08
HUP0302940A2 (hu)	2003-12-29
CA2416819C (en)	2011-03-22
PL365701A1 (pl)	2005-01-10
BG107529A (bg)	2003-09-30
NO330055B1 (no)	2011-02-14
AU2001273493B2 (en)	2005-08-11
NO20030299D0 (no)	2003-01-20
EP1305082B1 (en)	2004-05-26
WO2002007822A3 (en)	2002-05-30
NO20030299L (no)	2003-03-12
DE60103546T2 (de)	2005-06-09

Publication	Publication Date	Title
US20090281179A1 (en)	2009-11-12	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache associated pain
AU2001273493A1 (en)	2002-05-02	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
EP1408954B1 (en)	2009-07-01	Carbamate compounds for use in preventing or treating neuropathic pain
AU2002354909B2 (en)	2006-10-05	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
AU2002322442B2 (en)	2007-06-07	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
AU2002354909A1 (en)	2003-05-22	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
AU2002322442A1 (en)	2003-05-22	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
HK1063435B (en)	2010-01-22	Carbamate compounds for use in preventing or treating neuropathic pain
ZA200401156B (en)	2005-06-22	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain.
HK1063288B (en)	2007-05-25	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
ZA200401155B (en)	2005-05-12	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain.